Streetbeat News

Products Services

AAPL

WLDS

Wearable Devices Ltd. (WLDS) shares surged after announcing the availability of preorders for its Mudra Band, designed for touchless operation of Apple's (AAPL) Apple Watch. The company plans to begin shipments in the second half of 2023.

Portfolio Pulse from Ryan Gustafson

May 25, 2023 | 6:34 pm

NFLX

Netflix has started rolling out its solution to ban password sharing, leading to users threatening to cancel their subscriptions. Subscribers who shared accounts now have to transfer their profile to a new membership or add an extra member for an additional $7.99 monthly fee.

Portfolio Pulse from Happy Mohamed

May 25, 2023 | 5:45 pm

AMC

MoviePass has relaunched nationwide with a new pricing model, offering access to over 4,000 movie theaters, including AMC Theaters, Regal Cinemas, and Cinemark. The new subscription plans range from $10 to $40 per month, with varying limits on the number of movies.

Portfolio Pulse from Happy Mohamed

May 25, 2023 | 5:25 pm

APLS

BIOVF

Apellis Pharmaceuticals' Phase 2 MERIDIAN study for amyotrophic lateral sclerosis (ALS) failed to meet its primary and key secondary endpoints. As a result, Apellis and Swedish Orphan Biovitrum plan to discontinue the development of systemic pegcetacoplan for ALS.

Portfolio Pulse from Vandana Singh

May 25, 2023 | 5:14 pm

COIN

Coinbase-backed blockchain network Base is preparing for a mainnet launch, contingent on testnet stability, a successful Bedrock upgrade by Optimism, and completion of audits and reviews. The upgrade is expected to enhance the security and robustness of the Optimism mainnet bridge, benefiting projects like Base. Prominent DeFi platforms such as Uniswap and Aave are considering deployment on Base once operational.

Portfolio Pulse from Murtuza Merchant

May 25, 2023 | 5:13 pm

BTAI

BioXcel Therapeutics announced mixed results from Part 1 of Phase 3 SERENITY III trial for BXCL501, a lower dose of Igalmi, in bipolar and schizophrenia-associated agitation. The results will enable the initiation of Part 2 for at-home use. BTAI shares are down 27.5%.

Portfolio Pulse from Vandana Singh

May 25, 2023 | 5:10 pm

VNDA

Vanda Pharmaceuticals announced positive Phase 3 study results for tradipitant in motion sickness, showing its effectiveness in preventing vomiting. The study was conducted on boats in the coastal waters of the U.S. with 365 participants.

Portfolio Pulse from Vandana Singh

May 25, 2023 | 5:08 pm

PFE

The FDA has approved Pfizer's Paxlovid for mild-to-moderate COVID-19 in high-risk adults. The approval is based on data from the EPIC clinical development program, which showed an 86% reduction in risk of hospitalization or death. Pfizer expects Paxlovid sales of $8 billion in 2023.

Portfolio Pulse from Vandana Singh

May 25, 2023 | 5:06 pm

BTAI

BioXcel Therapeutics reported data from Part 1 of its SERENITY III trial, causing its shares to trade lower.

Portfolio Pulse from Benzinga Newsdesk

May 25, 2023 | 4:55 pm

SPY

VGK

Top U.S. General has stated that Ukraine is effectively using the Patriot Missile System against Russia. This could potentially impact defense-related stocks and ETFs such as SPY and VGK.

Portfolio Pulse from Happy Mohamed

May 25, 2023 | 4:43 pm